Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.

Summary Expression Phenotypes Gene Literature (85) GO Terms (7) Nucleotides (126) Proteins (71) Interactants (356) Wiki
XB--6085046

Papers associated with erg (and morpholino)



???displayGene.coCitedPapers???
Show all erg papers

???pagination.result.count???

???pagination.result.page??? 1

Sort Newest To Oldest Sort Oldest To Newest

referenced by:


Annexin A3 Regulates Early Blood Vessel Formation., Meadows SM, Cleaver O., PLoS One. July 16, 2015; 10 (7): e0132580.            


VEGFA-dependent and -independent pathways synergise to drive Scl expression and initiate programming of the blood stem cell lineage in Xenopus., Ciau-Uitz A, Pinheiro P, Kirmizitas A, Zuo J, Patient R., Development. June 1, 2013; 140 (12): 2632-42.                                                                                                                            


VEGFA-dependent and -independent pathways synergise to drive Scl expression and initiate programming of the blood stem cell lineage in Xenopus., Ciau-Uitz A, Pinheiro P, Kirmizitas A, Zuo J, Patient R., Development. June 1, 2013; 140 (12): 2632-42.                                                                                                                            


Evolutionarily repurposed networks reveal the well-known antifungal drug thiabendazole to be a novel vascular disrupting agent., Cha HJ, Byrom M, Mead PE, Ellington AD, Wallingford JB, Marcotte EM., PLoS Biol. January 1, 2012; 10 (8): e1001379.                  


Evolutionarily repurposed networks reveal the well-known antifungal drug thiabendazole to be a novel vascular disrupting agent., Cha HJ, Byrom M, Mead PE, Ellington AD, Wallingford JB, Marcotte EM., PLoS Biol. January 1, 2012; 10 (8): e1001379.                  


Systematic discovery of nonobvious human disease models through orthologous phenotypes., McGary KL, Park TJ, Woods JO, Cha HJ, Wallingford JB, Marcotte EM., Proc Natl Acad Sci U S A. April 6, 2010; 107 (14): 6544-9.                                    


ETS family protein ETV2 is required for initiation of the endothelial lineage but not the hematopoietic lineage in the Xenopus embryo., Salanga MC, Meadows SM, Myers CT, Krieg PA., Dev Dyn. April 1, 2010; 239 (4): 1178-87.                            


ETS family protein ETV2 is required for initiation of the endothelial lineage but not the hematopoietic lineage in the Xenopus embryo., Salanga MC, Meadows SM, Myers CT, Krieg PA., Dev Dyn. April 1, 2010; 239 (4): 1178-87.                            


Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation., Xu K, Chong DC, Rankin SA, Rankin SA, Zorn AM, Cleaver O., Dev Biol. May 15, 2009; 329 (2): 269-79.      


Rasip1 is required for endothelial cell motility, angiogenesis and vessel formation., Xu K, Chong DC, Rankin SA, Rankin SA, Zorn AM, Cleaver O., Dev Biol. May 15, 2009; 329 (2): 269-79.      


Enhancement of axonal regeneration by in vitro conditioning and its inhibition by cyclopentenone prostaglandins., Tonge D, Chan K, Zhu N, Panjwani A, Arno M, Lynham S, Ward M, Snape A, Pizzey J., J Cell Sci. August 1, 2008; 121 (Pt 15): 2565-77.                        


A Myc-Slug (Snail2)/Twist regulatory circuit directs vascular development., Rodrigues CO, Nerlick ST, White EL, Cleveland JL, King ML., Development. June 1, 2008; 135 (11): 1903-11.              


Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo., Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA., Dev Biol. August 1, 2006; 296 (1): 177-89.                  


Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo., Cox CM, D'Agostino SL, Miller MK, Heimark RL, Krieg PA., Dev Biol. August 1, 2006; 296 (1): 177-89.                  

???pagination.result.page??? 1